Почетна › Метастатски карцином › Тексас › San Antonio
Kliničke studije za Метастатски карцином u gradu San Antonio, TX
44 studija za Метастатски карцином traži učesnike na lokacijama u gradu San Antonio i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Study Site, San Antonio
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- UT Health San Antonio's Mays Cancer Center, San Antonio
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Тражи се учесникФаза 3
- Jason Bates at University of Texas Health Science Center, San Antonio
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Тражи се учесникФаза 3
- Texas Oncology - San Antonio, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Тражи се учесникФаза 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Тражи се учесникФаза 3
- Texas Oncology - San Antonio Medical Center, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
Тражи се учесникФаза 1
- START San Antonio, LLC, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Тражи се учесникФаза 1
- USA Clinical Trials, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, San Antonio
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- University of Texas Health Science Center at San Antonio, San Antonio
A Study of ASP3082 in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, San Antonio
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Тражи се учесникФаза 3
- Mays Cancer Center, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Texas San Antonio (UTSA), San Antonio
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
SLV-154 Treatment of Advanced Cancers
Тражи се учесникФаза 1
- Mays Cancer Center; University of Texas Health San Antonio, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Тражи се учесникФаза 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics (START) - San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Next Oncology, San Antonio
IDOV-Immune for Advanced Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, LLC., San Antonio
A Study of PYX-201 in Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT San Antonio, San Antonio
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #2, San Antonio
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- START, San Antonio
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Тражи се учесникФаза 1
- Texas Liver Institute, San Antonio
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Тражи се учесникФаза 1/2
- Next Oncology, San Antonio
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Тражи се учесникФаза 1/2
- Next Oncology, San Antonio
- The Start Center for Cancer Care, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- UT Health, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- START San Antonio, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
Studije za Метастатски карцином u drugim gradovima
- Houston, TX100 студија
- New York City, NY93 студија
- Nashville, TN69 студија
- Boston, MA61 студија
- Los Angeles, CA57 студија
- Arlington, VA52 студија
- St. Louis, MO52 студија
- Washington, DC44 студија
- Dallas, TX44 студија
- Philadelphia, PA42 студија
- Chicago, IL42 студија
- Seattle, WA39 студија
Ostale studije u gradu San Antonio
- Немалоклетни карцином плућа60 студија
- Рак дојке45 студија
- Колоректални карцином43 студија
- Рак (све врсте)41 студија
- Гојазност39 студија
- Dijabetes tipa 237 студија
- Гојазност34 студија
- Рак јајника33 студија
- Рак панкреаса33 студија
- Рак плућа27 студија
- Рак простате27 студија
- Карцином ендометријума27 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.